Title : The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors.

Pub. Date : 2019 May 17

PMID : 31101877






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The tamoxifen-responsive conditional Cdh5-CreERT2 is commonly used for endothelial cell specific conditional deletion of loxP-flanked gene sequences. Tamoxifen mitogen-activated protein kinase 3 Mus musculus
2 To address the role of endothelial cell Shb gene for B16F10 melanoma immune responses, tamoxifen-injected Cdh5-CreERT2/WT and Cdh5-CreERT2/Shbflox/flox mice received subcutaneous tumor cell injections. Tamoxifen mitogen-activated protein kinase 3 Mus musculus
3 We observed a decrease of tumor myeloid cell Shb mRNA in the tamoxifen treated Cdh5-CreERT2/Shbflox/flox mice, which was not present when the mice had undergone a preceding bone marrow transplantation using wild type bone marrow. Tamoxifen mitogen-activated protein kinase 3 Mus musculus
4 In the spleen, however, floxing was undetectable two months after tamoxifen treatment, suggesting that Cdh5-CreERT2 is operating in a non-renewable population of hematopoietic cells in this organ. Tamoxifen mitogen-activated protein kinase 3 Mus musculus